Oxford Nanopore Technologies and KAUST collaborate to advance multi-omics discovery

Oxford Nanopore Technologies and King Abdullah University of Science and Technology (KAUST) have signed a Memorandum of Understanding (MoU) to collaborate on the research and development of advanced multi-omics technologies. This strategic collaboration will leverage Oxford Nanopore's innovative nanopore sequencing technology and KAUST’s strong research base to accelerate scientific discoveries that address critical global health [...]

ReSync Bio Launches to Automate Data and Operations in Drug Discovery

ReSync announces round of pre-seed funding from Caffeinated Capital, Atria Ventures, and Ramsey Homsany, co-founder of Octant Bio The company’s platform is designed to be a plug-and-play tool that streamlines how companies manage data and advance assets SAN FRANCISCO -- ReSync Bio, a scientific software provider accelerating preclinical R&D, today announced the company’s launch and [...]

Vanderbilt University School of Medicine Basic Sciences Adds Carterra’s LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care

The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra’s platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules  Salt Lake City, Utah and Nashville, Tennessee – Carterra® Inc., the world leader in innovative technologies enabling high-throughput biology, and the Vanderbilt [...]

BERTRAM CAPITAL PARTNERS WITH LABORATORY EQUIPMENT AND ADVANCED MATERIALS PROVIDER MSE SUPPLIES

FOSTER CITY, Calif. -- Bertram Capital ("Bertram") announced today its investment in MSE Supplies, LLC ("MSE " or the "Company"). MSE, based in Tucson, AZ, is a supplier of advanced materials, laboratory equipment, lab supplies, and analytical services. MSE supports scientists and engineers in more than 100 countries with an offering of more than 10,000 products. MSE represents the [...]

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities SAN DIEGO -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient and scalable biofoundries, delivering solutions for sustainable and rapid on-premise synthesis of DNA. This innovative approach enabled by Telesis Bio’s Gibson SOLA [...]

Promega Engineers New Enzyme to Significantly Reduce Stutter in Forensic DNA Analysis

Promega files patent for first-of-its-kind enzyme that minimizes stutter artifacts in STR analysis Reduced stutter polymerase enhances accuracy, efficiency and reliability of DNA profiling in forensic laboratories Novel enzyme will be used in upcoming 8-color STR analysis kits manufactured by Promega Madison, WI USA. -- A novel enzyme developed by research scientists at Promega Corporation will [...]

Molecular Designs Announces Acquisition of Lamda Biotech

BIRMINGHAM, Ala. and ST. LOUIS -- Molecular Designs, a leading provider of PCR assays, associated reagents and equipment, is excited to announce the acquisition of Lamda Biotech, a specialized provider of research products for application in molecular biology, functional genomics, proteomics and gene therapy. This partnership will enhance Molecular Designs' product portfolio, grow its reach into [...]

Immunofluorescent staining within hours, not days

AMSBIO has launched CellO-IF – an all-in-one immunofluorescent staining reagent kit designed to accelerate the labelling organoids and spheroids directly in hydrogels or extracellular matrices, while preserving delicate structures and cellular integrity. Immunofluorescence (IF) allows detection and localization of antigens in diverse types of tissues in various cell preparations. The technique provides excellent sensitivity and amplification of signal by comparison to immunohistochemistry. [...]

Cytiva and Pear Bio empower personalized cancer medicine with innovative single-cell technology

Setting new benchmarks in cancer treatment research, Cytiva's Via Extractor tissue disaggregator is being used to create dissociated tumor cell suspensions with high viability and yield. The collaboration focuses on improving patient outcomes through the ​personalized ​evaluation of ​treatment efficacy on ​patient-derived tumors. Cytiva, a global leader in life sciences, and Pear Bio, a pioneer [...]

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy annually beginning in 2026 Avantor continues to implement global solar installations, with more planned in 2025 RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life [...]

Access IBO on Knowledge Center